Augmedix (OTCMKTS:AUGX) Price Target Lowered to $4.50 at B. Riley

Augmedix (OTCMKTS:AUGXGet Rating) had its price objective cut by B. Riley from $6.50 to $4.50 in a research report report published on Monday, The Fly reports.

Augmedix Price Performance

Shares of OTCMKTS AUGX opened at $1.60 on Monday. The firm’s 50-day moving average price is $1.79 and its 200-day moving average price is $2.34. Augmedix has a 1-year low of $1.42 and a 1-year high of $6.22. The firm has a market capitalization of $59.85 million, a P/E ratio of -2.67 and a beta of -1.01. The company has a current ratio of 3.04, a quick ratio of 3.04 and a debt-to-equity ratio of 0.66.

Augmedix (OTCMKTS:AUGXGet Rating) last announced its quarterly earnings data on Thursday, May 12th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Augmedix had a negative net margin of 77.52% and a negative return on equity of 251.74%. The company had revenue of $6.99 million for the quarter, compared to analyst estimates of $6.91 million. Equities research analysts anticipate that Augmedix will post -0.61 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Augmedix

A number of institutional investors have recently added to or reduced their stakes in the company. Perkins Capital Management Inc. grew its position in Augmedix by 2.4% in the 2nd quarter. Perkins Capital Management Inc. now owns 439,500 shares of the company’s stock worth $791,000 after purchasing an additional 10,500 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in Augmedix in the 2nd quarter worth about $592,000. Millrace Asset Group Inc. grew its position in Augmedix by 16.9% in the 2nd quarter. Millrace Asset Group Inc. now owns 909,492 shares of the company’s stock worth $1,637,000 after purchasing an additional 131,708 shares in the last quarter. Samjo Capital LLC bought a new position in shares of Augmedix during the 1st quarter valued at approximately $779,000. Finally, State Street Corp bought a new position in shares of Augmedix during the 1st quarter valued at approximately $34,000. 59.03% of the stock is owned by institutional investors.

About Augmedix

(Get Rating)

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals.

See Also

The Fly logo

Analyst Recommendations for Augmedix (OTCMKTS:AUGX)

Want More Great Investing Ideas?

Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.